24/7 Market News Snapshot 26 Jul 2024 – Cognition Therapeutics, Inc. Common Stock (NASDAQ: CGTX)

July 26, 2024 3:19

Press Release

DENVER, Colo., 26 July, 2024 (247marketnews.com) – (NASDAQ:CGTX) are discussed in this article.
Cognition Therapeutics, Inc. Common Stock (CGTX) exhibited remarkable bullish momentum today, with a notable surge from an opening price of $2.11 to a closing price of $2.35, reflecting a substantial 72.95% increase. This positive market movement underscores growing investor confidence in CGTX and hints at a favorable outlook for the company’s future growth and profitability.

In line with its commitment to advancing innovative solutions for neurodegenerative disorders, Cognition Therapeutics, Inc. (NASDAQ:CGTX) is gearing up to host a pivotal investor webcast on Monday, July 29, 2024, at 8:30 a.m. ET. The webcast will offer a deep dive into the clinical outcomes, safety profiles, and biomarker revelations stemming from the Phase 2 COG0201 “SHINE” study, a pivotal exploration in Alzheimer’s disease research.

During the study, 153 participants with mild-to-moderate Alzheimer’s disease underwent a six-month regimen of CT1812 (100mg or 300mg) or a placebo, paving the way for significant findings in the realm of neurodegenerative treatments.

Interested attendees can secure their spots by registering online for the webcast, which promises to provide a comprehensive understanding of the study’s implications and advancements. The event will also be archived on the Cognition website, ensuring broader accessibility for stakeholders keen on delving into the groundbreaking research outcomes.

Through this educational and informative initiative, Cognition Therapeutics, Inc. showcases its unwavering dedication to pioneering solutions in neurodegenerative healthcare. The upcoming webcast is poised to shed light on the Company’s progressive strides and their potential to revolutionize the therapeutic landscape for individuals grappling with neurodegenerative conditions.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 Market News, Inc Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.